Professor of Dermatology, University Pennsylvania
Dermatology
Dr. Victoria P. Werth, MD
|
|
Give Review
Victoria Werth practices Dermatology. She graduated from Johns Hopkins University School of Medicine. Johns Hopkins University School of Medicine is a top medical university. Johns Hopkins University School of Medicine is ranked 3 in research and 29 in primary care medicine She received 8 awards: "Philadelphia Magazine", "America's Top Doctors", "CMS Meaningful Use Stage 1 Certification", "Fellow (FAAD)", "Fellow", "Top MD", "Super Doctor" and "Fellow (FACR)". Victoria Werth is a published MD. She published 99 publications, including: 'Using the American College of Rheumatology (ACR) and Systemic Lupus International Collaborating Clinics (SLICC) criteria to determine the diagnosis of systemic lupus e...' She is registered with Medicare.
Publications
- Using the American College of Rheumatology (ACR) and Systemic Lupus International Collaborating Clinics (SLICC) criteria to determine the diagnosis of systemic lupus e...
- A cross-sectional study of untreated depression and anxiety in cutaneous lupus erythematosus and Dermatomyositis.
- Reliability and Validity of Cutaneous Sarcoidosis Outcome Instruments Among Dermatologists, Pulmonologists, and Rheumatologists.
- A multicentre randomized trial of the treatment of patients with Pemphigus vulgaris with infliximab and prednisone compared with prednisone alone.
- The role of cytokines in the pathogenesis of cutaneous lupus Erythematosus.
- From Pathogenesis, Epidemiology, and Genetics to Definitions, Diagnosis, and Treatments of Cutaneous Lupus Erythematosus and Dermatomyositis: A Report from the 3rd Int...
- Anti-C1q antibodies in systemic lupus Erythematosus.
- Definitions and outcome measures for mucous membrane Pemphigoid: Recommendations of an international panel of experts.
- Thalidomide-induced orofacial neuropathy.
- Challenges in measuring outcomes: Size assessment of an individual cutaneous Lesion.
- Improvement in the cutaneous disease activity of patients with Dermatomyositis is associated with a better quality of life.
- Lenalidomide in treatment-refractory cutaneous lupus Erythematosus: Efficacy and safety in a 52-week trial.
- Scoring Systems for Blistering Diseases in Practice: Why Bother, and Which One Should You Use?
- Systemic Symptoms in the Progression of Cutaneous to Systemic Lupus Erythematosus.
- The Impact of Skin Damage Due to Cutaneous Lupus on Quality of Life.
- Pemphigus.
- Oral Mucosal Involvement in Bullous Lupus.
- Update on pathogenesis and treatment of CLE.
- Treatment of dermatologic connective tissue disease and autoimmune blistering disorders in pregnancy.
- Cutaneous lupus Erythematosus: Diagnosis and treatment.
- Reliability and convergent validity of the cutaneous sarcoidosis activity and morphology instrument for assessing cutaneous sarcoidosis.
- Characterization of clinical photosensitivity in cutaneous lupus Erythematosus.
- A multicentre, cross-sectional study on quality of life in patients with cutaneous lupus Erythematosus.
- The importance of including amyopathic Dermatomyositis in the idiopathic inflammatory myositis spectrum.
- The interferon-regulated gene signature is elevated in subacute cutaneous lupus Erythematosus and discoid lupus Erythematosus and correlates with the cutaneous lupus a...
- Update on management of connective tissue panniculitides.
- Evaluation of Reliability, Validity, and Responsiveness of the CDASI and the CAT-BM.
- Tumour necrosis factor-alpha release in peripheral blood mononuclear cells of cutaneous lupus and Dermatomyositis patients.
- Severity score indexes for blistering diseases.
- Quality of life in patients with bullous dermatoses.
- Impact of Smoking in Cutaneous Lupus Erythematosus.
- Definitions and outcome measures for bullous Pemphigoid: Recommendations by an international panel of experts.
- Cigarette smoking and response to antimalarials in cutaneous lupus Erythematosus patients: evolution of a dogma.
- Dapsone in the management of autoimmune bullous diseases.
- The international pemphigus and Pemphigoid foundation.
- Lenalidomide therapy in treatment-refractory cutaneous lupus Erythematosus: Histologic and circulating leukocyte profile and potential risk of a systemic lupus flare.
- Identification of specific chondroitin sulfate species in cutaneous autoimmune disease.
- Response to Antimalarial Agents in Cutaneous Lupus Erythematosus: A Prospective Analysis.
- Prevalence of self-report photosensitivity in cutaneous lupus Erythematosus.
- Generating Consensus Research Goals and Treatment Strategies for Pemphigus and Pemphigoid: The 2010 JC Bystryn Pemphigus and Pemphigoid Meeting.
- A systematic review of randomized controlled trials for Pemphigus vulgaris and Pemphigus foliaceus.
- Quality of life in cutaneous lupus Erythematosus.
- Animal Models of Acute Photodamage: Comparisons of Anatomic, Cellular and Molecular Responses in C57BL/6J, SKH1 and Balb/c Mice.
- Treatment of Cutaneous Lupus.
- Rituximab in the treatment of bullous systemic lupus Erythematosus.
- Dermatomyositis autoantibodies: clinical markers of patients past, present, and future.
- Identification and molecular analysis of glycosaminoglycans in cutaneous lupus erythematosus and Dermatomyositis.
- Development of the CLASI as a tool to measure disease severity and responsiveness to therapy in cutaneous lupus Erythematosus.
- Update on morphea: part II. Outcome measures and treatment.
- Update on morphea: part I. Epidemiology, clinical presentation, and pathogenesis.
- Squamous cell carcinomas arising in discoid lupus Erythematosus scars: unusual occurrence in an African-American and in a sun-protected area.
- Ultraviolet irradiation induces the accumulation of chondroitin sulfate, but not other glycosaminoglycans, in human Skin.
- Mycophenolate mofetil for interstitial lung disease in Dermatomyositis.
- Tumor necrosis factor inhibitor-associated Dermatomyositis.
- Interstitial lung disease in classic and Skin-predominant dermatomyositis: a retrospective study with screening recommendations.
- Prevention and treatment of systemic glucocorticoid side effects.
- Cutaneous lupus and the Cutaneous Lupus Erythematosus Disease Area and Severity Index instrument.
- Rheumatic manifestations of Skin disease.
- A case of localized scleroderma in a sculptor and his wife.
- Reliability and convergent validity of two outcome instruments for Pemphigus.
- Pregnancy-associated Dermatomyositis.
- Analysis of compact fluorescent lights for use by patients with photosensitive conditions.
- Sweet syndrome associated with new-onset systemic lupus Erythematosus in a 25-year-old man.
- UVB and proinflammatory cytokines synergistically activate TNF-alpha production in keratinocytes through enhanced gene transcription.
- Lenalidomide for the treatment of resistant discoid lupus Erythematosus.
- The role of case reports in evidence-based practice, with suggestions for improving their reporting.
- Cross-sectional analysis of a collaborative Web-based database for lupus erythematosus-associated Skin lesions: prospective enrollment of 114 patients.
- Comparison of the reliability and validity of outcome instruments for cutaneous Dermatomyositis.
- Quality of life and disease severity in a cutaneous lupus Erythematosus pilot study.
- Cutaneous Mycobacterium haemophilum infection in iatrogenically immunocompromised patients without transplantation.
- Consensus statement on definitions of disease, end points, and therapeutic response for Pemphigus.
- The cutaneous lupus disease activity and severity index as a validated outcome measure for cutaneous lupus Erythematosus: comment on the article by Stamm et al.
- The cutaneous lupus Erythematosus disease area and severity index: a responsive instrument to measure activity and damage in patients with cutaneous lupus Erythematosus.
- Multicenter randomized, double-blind, placebo-controlled, clinical trial of dapsone as a glucocorticoid-sparing agent in maintenance-phase Pemphigus vulgaris.
- What is new in the treatment of steroid-induced osteoporosis?
- Number, characteristics, and classification of patients with Dermatomyositis seen by dermatology and rheumatology departments at a large tertiary medical center.
- Pathophysiology of cutaneous lupus Erythematosus.
- Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis: a case series of nine patients and review of the literature.
- Cutaneous lupus: insights into pathogenesis and disease classification.
- Medical dermatology: a view to the future.
- Improvement in Dermatomyositis rash associated with the use of antiestrogen medication.
- Cross-sectional study of bisphosphonate use in dermatology patients receiving long-term oral corticosteroid therapy.
- The CLASI (Cutaneous Lupus Erythematosus Disease Area and Severity Index): an outcome instrument for cutaneous lupus Erythematosus.
- Combination antimalarials in the treatment of cutaneous Dermatomyositis: a retrospective study.
- Ultraviolet-B recruits mannose-binding lectin into Skin from non-cutaneous sources.
- Dapsone as a glucocorticoid-sparing agent in maintenance-phase Pemphigus vulgaris.
- Activation of autoimmunity following use of immunostimulatory herbal supplements.
- Lupus Erythematosus induced by medications, ultraviolet radiation, and other exogenous agents: a review, with special focus on the development of subacute cutaneous lu...
- Photosensitivity in rheumatic diseases.
- Darier's disease associated with an underlying neoplasm in combination with a nodular fibroproliferative disease.
- Stroke and deep venous thrombosis complicating intravenous immunoglobulin infusions.
- Cutaneous infections of the head and neck.
- Multicentric reticulohistiocytosis presenting with clinical features of Dermatomyositis.
- Modification to the approach of the diagnosis of mucous membrane Pemphigoid: A case report and literature review.
- IL-12 completely blocks ultraviolet-induced secretion of tumor necrosis factor alpha from cultured Skin fibroblasts and keratinocytes.
- Mannose binding lectin (MBL) polymorphisms associated with low MBL production in patients with Dermatomyositis.
- Deletion of decay-accelerating factor (CD55) exacerbates autoimmune disease development in MRL/lpr mice.
- Treatment of bullous Pemphigoid with topical corticosteroids: review of a randomized controlled trial.
Schools
Johns Hopkins University School Of Medicine
Northwestern Meml Hospital
New York University
New York University School Of Med
Procedures Preformed
- Destruction of Benign Skin Lesion
- Destruction of Malignant Skin Lesion
Conditions Treated
- Acne
- Actinic Keratosis
- Atopic Dermatitis (Eczema)
- Benign Skin Lesion
- View All
Doctors Specialties
- Dermatology
Accepted Insurances
Awards
- Philadelphia Magazine
- America's Top Doctors
- CMS Meaningful Use Stage 1 Certification
- Fellow (FAAD)
- Fellow
- Top MD
- Super Doctor
- Fellow (FACR)
Education
-
NYU School of Medicine -
McGaw Medical Center of Northwestern University -
Johns Hopkins University School of Medicine
Hospital
-
Hospital of the University of Pennsylvania -
Penn Presbyterian Medical Center -
Pennsylvania Hospital -
Philadelphia Veterans Affairs Medical Center
Drug Facts
| NPI NUMBER | 1689609281 | |
| NPPES Provider LastName | WERTH | |
| NPPES Provider FirstName | VICTORIA | |
| NPPES Provider ZIPCode | 19104 | |
| NPPES Provider State | PA | |
| Specialty Description | Dermatology | |
| Total Claim Count | 814.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1689609281 |
| Last Name Of The Provider | WERTH |
| First Name Of The Provider | VICTORIA |
| View All |
Similar Doctors
|
|
Dr. Jeanyoung Kim, MD |
|
|
Dr. Joy Wan, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Filiberto Cedeno Laurent, MD |
|
|
Dr. Zelma C. Chiesa Fuxench, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Barbara M. Mathes, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Maryam S. Haque, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Melinda V. Jen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Aimee S. Payne, MD
This Doctor is OpenDoctor Recommended.
|